Oral Contraceptive Initial

download Oral Contraceptive Initial

of 3

Transcript of Oral Contraceptive Initial

  • 8/3/2019 Oral Contraceptive Initial

    1/3

    Characteristics Type of OC Indicated Suggested OC for Initial

    Cylces (see table 2)

    Regular light menses. 2-4 days flow: mild or

    no cramps

    Low endometrial activity Groups 3,6,8

    Regular moderate menses. 4-6 days flow:moderate cramps

    Intermediate endometrial activity Groups 2, 4, 5, 7, 9, 10,11

    Regular heavy menses. 6 plus days flow:severe cramps High endometrial activity Group 13

    Irregular and infrequent menses,hypermenorrhea whon occurs: associated

    acne, oily skin, hirsutism

    Probably polycystic ovarian syndrome.High progestional and low androgenic

    activity desireable.

    Groups 2, 6, 7, 8, 10

    Irregular menses, hypomenorrhea when

    occurs: no adreogen effects

    If galactorrhea present, possible pituitary

    adenoma. Skull x-ray or prolactin needed.If no galactorrhea, low estrogen and low

    progestational activity combination OCs

    or multiphasic OCs may be used

    Groups 1, 5, 8 , barrier

    and spermicidal methods

    Smokers- ages 35+ Combination OCs contraindicated Group 1, barrier and

    spermicidal methods

    Nonsmokers- 35+ Sub 35 mcg estrogen, intermediate/high

    progestin, combination OC

    20-25 mcg EE Ocs from

    groups 2, 3, 5, 7, 8Weight less than 110 lbs Lower estrogen and low progestin dose Groups 5, 7, 8 or any tri-phasic

    Weight more than 160 lbs High estrogen and intermediate to highprogestin

    Group 11, 12, 13

    Progesterone hypersensitivity: history of

    toxemia, stong family history of hypertension,

    excessive weight gain, tiredness or variconeveins during pregnancy, depression, excessive

    premenstrual edema

    Low progestin does and progestational

    activity. Monitor blood pressure.

    Groups 1, 8, 10

    (antimineralocorticoid

    activity) or any triphasic

    Estrogen hypersensitivity: excessive nausea,

    edema or hypotsn in pregnancy,hypertrophy of

    cervix or uterus, uterine fibrios, large or

    fibrocstic breasts; heavy menses, migraine

    Low estrogenic activity Group 1 or any 20 mcg

    EE OC

    Conditions predisposing to cardiovascular

    disease type ii hyperlipidemia (high

    cholesterol) diabetes mellitus, obesity,

    smoking more than 15 cigarettes per day,

    hypertension, varicose veins, thrombophlebitis

    during pregnancy, family of cardiovascular

    disease before age 50

    Combination pills not recommended. Group 1, barrier and

    spermicidal methods

    Surgery planned within 1-4 weeks Combination pills should be stopped Group 1, barrier and

    spermicidal methods

  • 8/3/2019 Oral Contraceptive Initial

    2/3

    Group Index name: Generic name Activity

    1 Micronor, Nor-QD: Camila, Errin,

    Jolivette, Nora-be Ovrette: Lybrel

    Endometrial: Low

    Progestational: Low

    Androgenic: low

    2 Mircette: Kariva, Desogen, Ortho-cept:

    Apri, reclipsen

    Endometrial:Intermediate

    Progestational: highAndrogenic: low

    3 Loestrin 1/20: Junel 1/20, Microgestin

    1/20 Loestrin 1/24: Loestrin 1.5/30; Junel1/50, Microgestin 1.5/30 Estrostep:

    Seasonale, Seasonique

    Endometrial: Low

    Progestational: intermediateAndrogenic: Intermediate

    4 LoOvral: Cryselle, Low-Ogesstrel

    NordetteL Levlen, Levora, Portia

    Endometrial:intermediate

    Progestational: intermediate

    Androgenic: intermediate

    5 Ortho Tri-Cyclen Lo: Ortho Tri-Cyclen:

    Triness, Tri-previfem, tri-sprintec Ortho-

    cyclen: monessa, privifem, sprintecTraphasil: Enpressse, tri-levlen, trivora

    Ovcon 25: Balziva

    Endometrial: intermediate

    Progestational: low

    Androgenic: low

    6 Demulen 1/35:kelnor, zovia 1/35 Endometrial: low

    Progestational: high

    Androgenic: low

    7 Cyclwaa: Velivet

    Ortho-vovum7/7/7: Nortel 7/7/7Orthonovum 10/11: Necon 10/11, Nelova

    10/11

    Endometrial:intermediate

    Progestational:intermediateAndrogenic:low

    8 Alesse: avianna, lessina, levlite, lybrel,

    lutera, sronyx Brevicon, modican: necon .5/35, nortral .5/35Tri-norinyl: arnelle

    Endometrial:low

    Progestational:lowAndrogenic:low

    9 Norinyl, ortho-novum 1/35; necon 1/35,

    nortrel 1/35

    Endometrial:intermediate

    Progestational:intermediate

    Androgenic:intermediate

    10 Yasmin yaz Endometrial:intermediate

    Progestational:higheAndrogenic:none

    11 Demulen 1/50: zovia 1/50 Endometrial: intermediateProgestational: high

    Androgenic: low

    12 Norinyl, ortho-novum 1/50M: necon1/50M, Nelova 1/50 M Norlestrin 1/50,

    ovcon 1/50

    Endometrial: intermediateProgestational: intermediate

    Androgenic: intermediate

    13 Ovral: ogestrel Endometrial: high

    Progestational: high

    Androgenic: high

  • 8/3/2019 Oral Contraceptive Initial

    3/3

    Taken from:

    Managing Contraceptive Pill Patents, Thirteenth edition, by Richard P. Dickey, MD, PhD